Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Atherosclerotic cardiovascular disease and stroke are the leading causes of morbidity and mortality worldwide. Along to the traditional risk factors for these diseases, chronic inflammation is known to be an important player in accelerating the process of atherosclerosis, which can result in an increased incidence of arterial thromboembolic events. As in other chronic inflammatory diseases, in the past few years, several studies suggested that subjects affected by inflammatory bowel diseases (IBD) may also be at an incremented risk of atherosclerotic disease, especially during the periods of disease's flare. Therefore, IBD treatment may assume an important role for achieving both disease remission and the control of the atherosclerotic risk. In this article we aimed to perform a comprehensive review on evidence on the increased risk of arterial thromboembolic events in patients affected by IBD and discuss the potential role of IBD therapy in reducing this risk.

Cite

CITATION STYLE

APA

Gabbiadini, R., Dal Buono, A., Mastrorocco, E., Solitano, V., Repici, A., Spinelli, A., … Armuzzi, A. (2023). Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue. Frontiers in Cardiovascular Medicine. Frontiers Media S.A. https://doi.org/10.3389/fcvm.2023.1143293

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free